What are the major opportunities in the Cell & Gene Therapy Manufacturing Services market? What are the strategies for the Cell & Gene Therapy Manufacturing Services market?

For detailed insights on the major opportunities and strategies in the Cell & Gene Therapy Manufacturing Services market, Read More

How does the Cell & Gene Therapy Manufacturing Services market relate to the overall economy and other similar markets?

For detailed insights on Cell & Gene Therapy Manufacturing Services's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Cell & Gene Therapy Manufacturing Services market growth? SWOT analysis of the Cell & Gene Therapy Manufacturing Services market.

For detailed insights on the key dynamics influencing the Cell & Gene Therapy Manufacturing Services market growth and SWOT analysis of the Cell & Gene Therapy Manufacturing Services industry, Read More

Global Cell & Gene Therapy Manufacturing Services Market Report 2025

Report Price : $4490.00

Pages : 200

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report

Cell & Gene Therapy Manufacturing Services Global Market Report 2025

Name: Cell & Gene Therapy Manufacturing Services Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Type (Gene Therapy, Cell Therapy), By Indication (Central Nervous System Disorders, Ophthalmology Diseases, Cardiovascular Diseases, Infectious Diseases, Orthopedic Diseases, Oncology Diseases), By Application (Commercial Manufacturing, Clinical Manufacturing), By End-user (Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Cell & Gene Therapy Manufacturing Services Market Overview

• Cell & Gene Therapy Manufacturing Services market size has reached to $8.15 billion in 2024

• Expected to grow to $17.92 billion in 2029 at a compound annual growth rate (CAGR) of 17.4%

• Growth Driver: Rising Prevalence Of Cancer And Other Target Diseases To Drive Market Growth

• Market Trend: Technological Advancements Driving Innovation In Cell And Gene Therapy Manufacturing Services Market

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cell & Gene Therapy Manufacturing Services Market?

Cell and gene therapy manufacturing services refer to the manufacturing and quality-testing services for gene and cell therapy products. It aids in the advancement and production of remedies for degenerative illnesses, tissue injuries, and genetic abnormalities. These services include good manufacturing practices ancillary reagents, flow cytometry, immunoassays, and gene engineering services.

The main types of cell and gene therapy manufacturing services include gene therapy and cell therapy. Gene therapy is a medical strategy that addresses the underlying genetic issue in order to treat or prevent disease. They are used for commercial manufacturing and clinical manufacturing applications for various indications including central nervous system disorders, ophthalmology diseases, cardiovascular diseases, infectious diseases, orthopedic diseases and oncology diseases. These services are used by academic and research institutes, pharmaceutical and biotechnology companies, and others.

Cell & Gene Therapy Manufacturing Services Market Size and growth rate 2025 to 2029: Graph

What Is The Cell & Gene Therapy Manufacturing Services Market Size 2025 And Growth Rate?

The cell & gene therapy manufacturing services market size has grown rapidly in recent years. It will grow from$8.15 billion in 2024 to $9.44 billion in 2025 at a compound annual growth rate (CAGR) of 15.9%. The growth in the historic period can be attributed to increased R&D investments, regulatory support and frameworks, growing pipeline of cell & gene therapies, industry collaborations and partnerships, increasing global demand for personalized medicine

What Is The Cell & Gene Therapy Manufacturing Services Market Growth Forecast?

The cell & gene therapy manufacturing services market size is expected to see rapid growth in the next few years. It will grow to $17.92 billion in 2029 at a compound annual growth rate (CAGR) of 17.4%. The growth in the forecast period can be attributed to market maturation and commercialization, global expansion of biopharmaceutical manufacturing, increased outsourcing by pharma companies, advancements in automation and robotics, emergence of new therapeutic modalities. Major trends in the forecast period include rising demand for energy efficiency, advanced materials and technologies, compact and modular designs, electrification of transportation, focus on safety and reliability.

The forecast of 17.4% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. advanced therapies by increasing costs for viral vector production and cell processing services imported from France and Singapore, potentially slowing life-saving treatment availability and raising production costs by 15-20%. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Cell & Gene Therapy Manufacturing Services Market Segmented?

1) By Type: Gene Therapy, Cell Therapy

2) By Indication: Central Nervous System Disorders, Ophthalmology Diseases, Cardiovascular Diseases, Infectious Diseases, Orthopedic Diseases, Oncology Diseases

3) By Application: Commercial Manufacturing, Clinical Manufacturing

4) By End-user: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

Subsegments:

1) By Gene Therapy: Viral Vector Manufacturing, Plasmid DNA Production, Gene Editing Services, Formulation And Fill-Finish Services

2) By Cell Therapy: Cell Sourcing And Banking, Cell Processing And Expansion, Quality Control And Testing Services, Cryopreservation And Storage Services

What Is Driving The Cell & Gene Therapy Manufacturing Services Market? Rising Prevalence Of Cancer And Other Target Diseases To Drive Market Growth

The high incidence of cancer and other target diseases is expected to propel the growth of the cell and gene therapy manufacturing services market going forward. Cancer is a severe disorder in which the body's cells reproduce fast and uncontrollably, resulting in abnormal growth. Cell and gene therapies are developing as promising new strategies to combat the rising incidence of cancer, which is driving the demand for novel and efficient treatment choices. For instance, in January 2023, according to the American Cancer Society, a US-based nonprofit cancer advocacy organization, the number of cancer cases increased from 1,898,160 in 2021 to 1,958,310 in 2023, reflecting a growth of 3.16%. Therefore, the high incidence of cancer and other target diseases is driving the growth of the cell and gene therapy manufacturing services market going forward.

What Is Driving The Cell & Gene Therapy Manufacturing Services Market? Rising Adoption Of Personalized Medicines To Drive Market Growth

The increasing adoption of personalized medicines is expected to propel the growth of cell and gene therapy manufacturing services market going forward. Personalized medicine is an innovative healthcare approach that tailor’s medical treatment and interventions to the individual characteristics of each patient. Personalized medicine enhances cell and gene therapy by tailoring treatments to an individual's unique genetic profile, enabling targeted therapies with optimized efficacy, reduced side effects, and improved patient outcomes. For instance, in January 2023, according to the Personalized Medicine Coalition, a US-based professional membership organization, the Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs) in 2022. Out of the 35 therapeutic NMEs, approximately 34%, which amounts to 12 of them, are classified as personalized medicines by the Personalized Medicine Coalition (PMC). Therefore, the increasing adoption of personalized medicine is driving the growth of the cell and gene therapy manufacturing services market

Who Are The Major Players In The Global Cell & Gene Therapy Manufacturing Services Market?

Major companies operating in the cell & gene therapy manufacturing services market include Thermo Fisher Scientific Inc., Merck KGaA, Charles River Laboratories International Inc., Lonza Group AG, Catalent Inc., WuXi AppTec, Takara Bio Inc., Nikon Corporation, Fujifilm Holdings Corporation, F. Hoffmann-La Roche Ltd, Oxford Biomedica plc, CGT Catapult, bluebird bio Inc., Boehringer Ingelheim International GmbH, Innovative Cellular Therapeutics Co. Ltd., Samsung Biologics Co. Ltd., Novartis International AG, Pfizer Inc., Brammer Bio, AGC Biologics, Cognate BioServices Inc., Paragon Bioservices Inc., Merck KGaA operating as MilliporeSigma, Sarepta Therapeutics Inc., Spark Therapeutics Inc., Orchard Therapeutics plc, Precision BioSciences Inc., PCT a Hitachi Group Company, Aldevron LLC, BioNTech SE

What Are The Key Trends Of The Global Cell & Gene Therapy Manufacturing Services Market? Technological Advancements Driving Innovation In Cell And Gene Therapy Manufacturing Services Market

Technological advancements are a key trend gaining popularity in the cell and gene therapy manufacturing services market. Major companies operating in the cell and gene therapy manufacturing services market are adopting new technologies to sustain their position in the market. For instance, in October 2022, Charles River Laboratories International Inc., a US-based pharmaceutical company specializing in various preclinical and clinical laboratory, gene therapy, and cell therapy services, launched the navigation Vector Platform (navigation). It is a platform that simplifies the path to GMP Adeno-Associated Virus (AAV) vector manufacturing without requiring extensive process development. Compared to standard manufacturing workflows, the navigation platform can cut a program's timeframe to GMP by 55% for viral vector gene therapy researchers. Charles River's navigation technique is based on a unique high-productivity HEK293 suspension cell line that can be scaled up and serotyped to meet clients' needs.

What Are The Key Trends Of The Global Cell & Gene Therapy Manufacturing Services Market? Strategic Collaborations Drive Advancements In Cell And Gene Therapy Manufacturing Services Market

Major companies operating in the cell and gene therapy manufacturing services market are forming partnerships to develop new products and strengthen their positions in the market. Collaborations and partnerships in the cell and gene therapy manufacturing services market foster innovation, leverage complementary expertise, and accelerate the development and commercialization of advanced therapies by combining resources and capabilities. For instance, in January 2022, Allogene Therapeutics Inc., a US-based biotechnology company collaborated with Antion Biosciences SA, a Switzerland-based biopharmaceutical company, to advance multiplex gene silencing for the development of next-generation allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer. The collaboration allows Allogene to deploy Antion's miCAR technology alongside other strategies to enhance immune evasion and advance allogeneic CAR T therapy, potentially creating more effective and tailored cell therapies.

Need data on a specific region in this market?

Request Customisation

Cell & Gene Therapy Manufacturing Services Market Merger And Acquisition: Genezen To Acquire Uniqure's Commercial Gene Therapy

In June 2024, Genezen, a US-based gene and cell therapy company acquired UniQure for an undisclosed amount. With this acquisition, Genezen aims to enhance its capabilities in gene therapy production, expanding its portfolio of services and leveraging UniQure's expertise to meet the growing demand for innovative gene therapies in the market. UniQure is a Netherlands-based biotechnology company specializing in gene therapies for severe diseases.

Regional Analysis For The Global Cell & Gene Therapy Manufacturing Services Market

North America was the largest region in the cell and gene therapy manufacturing services market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global cell & gene therapy manufacturing services market report forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Cell & Gene Therapy Manufacturing Services Market?

The cell and gene therapy manufacturing services market includes revenues earned by cell and gene therapy manufacturing and related services which include analytical and process development, current good manufacturing practice cell therapy manufacturing services of autologous and allogeneic t-cells, natural killer cells, dendritic cells, mesenchymal stem cells, hematopoietic stem cells, and more. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Cell & Gene Therapy Manufacturing Services Industry?

The cell & gene therapy manufacturing services market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cell & gene therapy manufacturing services industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Cell & Gene Therapy Manufacturing Services Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$9.44 billion
Revenue Forecast In 2034	$17.92 billion
Growth Rate	CAGR of 17.4% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Type: Gene Therapy, Cell Therapy 2) By Indication: Central Nervous System Disorders, Ophthalmology Diseases, Cardiovascular Diseases, Infectious Diseases, Orthopedic Diseases, Oncology Diseases 3) By Application: Commercial Manufacturing, Clinical Manufacturing 4) By End-user: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users Subsegments: 1) By Gene Therapy: Viral Vector Manufacturing, Plasmid DNA Production, Gene Editing Services, Formulation And Fill-Finish Services 2) By Cell Therapy: Cell Sourcing And Banking, Cell Processing And Expansion, Quality Control And Testing Services, Cryopreservation And Storage Services
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Thermo Fisher Scientific Inc., Merck KGaA, Charles River Laboratories International Inc., Lonza Group AG, Catalent Inc., WuXi AppTec, Takara Bio Inc., Nikon Corporation, Fujifilm Holdings Corporation, F. Hoffmann-La Roche Ltd, Oxford Biomedica plc, CGT Catapult, bluebird bio Inc., Boehringer Ingelheim International GmbH, Innovative Cellular Therapeutics Co. Ltd., Samsung Biologics Co. Ltd., Novartis International AG, Pfizer Inc., Brammer Bio, AGC Biologics, Cognate BioServices Inc., Paragon Bioservices Inc., Merck KGaA operating as MilliporeSigma, Sarepta Therapeutics Inc., Spark Therapeutics Inc., Orchard Therapeutics plc, Precision BioSciences Inc., PCT a Hitachi Group Company, Aldevron LLC, BioNTech SE
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Cell & Gene Therapy Manufacturing Services Market Characteristics

3. Cell & Gene Therapy Manufacturing Services Market Trends And Strategies

4. Cell & Gene Therapy Manufacturing Services Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cell & Gene Therapy Manufacturing Services Growth Analysis And Strategic Analysis Framework

5.1. Global Cell & Gene Therapy Manufacturing Services PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Cell & Gene Therapy Manufacturing Services Market Growth Rate Analysis

5.4. Global Cell & Gene Therapy Manufacturing Services Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Cell & Gene Therapy Manufacturing Services Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Cell & Gene Therapy Manufacturing Services Total Addressable Market (TAM)

6. Cell & Gene Therapy Manufacturing Services Market Segmentation

6.1. Global Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Gene Therapy

Cell Therapy

6.2. Global Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Central Nervous System Disorders

Ophthalmology Diseases

Cardiovascular Diseases

Infectious Diseases

Orthopaedic Diseases

Oncology Diseases

6.3. Global Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Commercial Manufacturing

Clinical Manufacturing

6.4. Global Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Academic And Research Institutes

Pharmaceutical And Biotechnology Companies

Other End-Users

6.5. Global Cell & Gene Therapy Manufacturing Services Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Viral Vector Manufacturing

Plasmid DNA Production

Gene Editing Services

Formulation And Fill-Finish Services

6.6. Global Cell & Gene Therapy Manufacturing Services Market, Sub-Segmentation Of Cell Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cell Sourcing And Banking

Cell Processing And Expansion

Quality Control And Testing Services

Cryopreservation And Storage Services

7. Cell & Gene Therapy Manufacturing Services Market Regional And Country Analysis

7.1. Global Cell & Gene Therapy Manufacturing Services Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Cell & Gene Therapy Manufacturing Services Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cell & Gene Therapy Manufacturing Services Market

8.1. Asia-Pacific Cell & Gene Therapy Manufacturing Services Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cell & Gene Therapy Manufacturing Services Market

9.1. China Cell & Gene Therapy Manufacturing Services Market Overview

9.2. China Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cell & Gene Therapy Manufacturing Services Market

10.1. India Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cell & Gene Therapy Manufacturing Services Market

11.1. Japan Cell & Gene Therapy Manufacturing Services Market Overview

11.2. Japan Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cell & Gene Therapy Manufacturing Services Market

12.1. Australia Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cell & Gene Therapy Manufacturing Services Market

13.1. Indonesia Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cell & Gene Therapy Manufacturing Services Market

14.1. South Korea Cell & Gene Therapy Manufacturing Services Market Overview

14.2. South Korea Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cell & Gene Therapy Manufacturing Services Market

15.1. Western Europe Cell & Gene Therapy Manufacturing Services Market Overview

15.2. Western Europe Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cell & Gene Therapy Manufacturing Services Market

16.1. UK Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cell & Gene Therapy Manufacturing Services Market

17.1. Germany Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cell & Gene Therapy Manufacturing Services Market

18.1. France Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cell & Gene Therapy Manufacturing Services Market

19.1. Italy Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cell & Gene Therapy Manufacturing Services Market

20.1. Spain Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cell & Gene Therapy Manufacturing Services Market

21.1. Eastern Europe Cell & Gene Therapy Manufacturing Services Market Overview

21.2. Eastern Europe Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cell & Gene Therapy Manufacturing Services Market

22.1. Russia Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cell & Gene Therapy Manufacturing Services Market

23.1. North America Cell & Gene Therapy Manufacturing Services Market Overview

23.2. North America Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cell & Gene Therapy Manufacturing Services Market

24.1. USA Cell & Gene Therapy Manufacturing Services Market Overview

24.2. USA Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cell & Gene Therapy Manufacturing Services Market

25.1. Canada Cell & Gene Therapy Manufacturing Services Market Overview

25.2. Canada Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cell & Gene Therapy Manufacturing Services Market

26.1. South America Cell & Gene Therapy Manufacturing Services Market Overview

26.2. South America Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cell & Gene Therapy Manufacturing Services Market

27.1. Brazil Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cell & Gene Therapy Manufacturing Services Market

28.1. Middle East Cell & Gene Therapy Manufacturing Services Market Overview

28.2. Middle East Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cell & Gene Therapy Manufacturing Services Market

29.1. Africa Cell & Gene Therapy Manufacturing Services Market Overview

29.2. Africa Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cell & Gene Therapy Manufacturing Services Market Competitive Landscape And Company Profiles

30.1. Cell & Gene Therapy Manufacturing Services Market Competitive Landscape

30.2. Cell & Gene Therapy Manufacturing Services Market Company Profiles

30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Charles River Laboratories International Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Catalent Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Cell & Gene Therapy Manufacturing Services Market Other Major And Innovative Companies

31.1. WuXi AppTec

31.2. Takara Bio Inc.

31.3. Nikon Corporation

31.4. Fujifilm Holdings Corporation

31.5. F. Hoffmann-La Roche Ltd

31.6. Oxford Biomedica plc

31.7. CGT Catapult

31.8. bluebird bio Inc.

31.9. Boehringer Ingelheim International GmbH

31.10. Innovative Cellular Therapeutics Co. Ltd.

31.11. Samsung Biologics Co. Ltd.

31.12. Novartis International AG

31.13. Pfizer Inc.

31.14. Brammer Bio

31.15. AGC Biologics

32. Global Cell & Gene Therapy Manufacturing Services Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cell & Gene Therapy Manufacturing Services Market

34. Recent Developments In The Cell & Gene Therapy Manufacturing Services Market

35. Cell & Gene Therapy Manufacturing Services Market High Potential Countries, Segments and Strategies

35.1 Cell & Gene Therapy Manufacturing Services Market In 2029 - Countries Offering Most New Opportunities

35.2 Cell & Gene Therapy Manufacturing Services Market In 2029 - Segments Offering Most New Opportunities

35.3 Cell & Gene Therapy Manufacturing Services Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Cell & Gene Therapy Manufacturing Services Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Cell & Gene Therapy Manufacturing Services Market, Sub-Segmentation Of Cell Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Cell & Gene Therapy Manufacturing Services Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Cell & Gene Therapy Manufacturing Services Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Indonesia, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: South Korea, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Western Europe, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: UK, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Germany, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: France, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Italy, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Spain, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Eastern Europe, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Russia, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: North America, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: USA, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Canada, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: South America, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Brazil, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Middle East, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Africa, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Thermo Fisher Scientific Inc. Financial Performance

Table 78: Merck KGaA Financial Performance

Table 79: Charles River Laboratories International Inc. Financial Performance

Table 80: Lonza Group AG Financial Performance

Table 81: Catalent Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Cell & Gene Therapy Manufacturing Services Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Cell & Gene Therapy Manufacturing Services Market, Sub-Segmentation Of Cell Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Cell & Gene Therapy Manufacturing Services Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Cell & Gene Therapy Manufacturing Services Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Indonesia, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: South Korea, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Western Europe, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: UK, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Germany, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: France, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Italy, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Spain, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Eastern Europe, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Russia, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: North America, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: USA, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Canada, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: South America, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Brazil, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Middle East, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Africa, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Thermo Fisher Scientific Inc. Financial Performance

Figure 78: Merck KGaA Financial Performance

Figure 79: Charles River Laboratories International Inc. Financial Performance

Figure 80: Lonza Group AG Financial Performance

Figure 81: Catalent Inc. Financial Performance

Latest Market Developments in Ketamine Clinic Industry: Forecast 2025–2029

Competitive and Market Trend Analysis of Lifestyle Diseases Apps Industry Through 2029

Industry Trends Show Locum Tenens Staffing Market Set to Expand at 11.6% CAGR Until 2029

In-Depth Lung Cancer Surgery Market Report: Business Trends, Growth Factors, and Forecast to 2029

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Fertility Services Market 2023 – By Procedure (Assisted Reproductive Technology (Art), In-Vitro Fertilization, Artificial Insemination), By Service (Fresh Non-Donor, Frozen Non-Donor, Egg And Embryo Banking, Fresh Donor,...

View Report

Value Based Care Payment Market 2023 – By Model (Accountable Care Organization (ACO), Bundled Payments, Patient-Centered Medical Home (PCMH), Pay For Performance (P4P)), By Deployment Type (Cloud Based, On-Premise), By E...

View Report

Dimension Stone Mining Global Market Report 2020 - By Type (Marble, Granite, Limestone, Sandstone)...

View Report

Stone Mining And Quarrying Global Market Report 2020 - By Type (Dimension Stone Mining, Crushed Stone Mining), By Organization Size (large Enterprises, Small And Medium Enterprises), COVID-19 Impact...

View Report

Truck Transportation Global Market Report 2020 - By Type (General Freight Trucking, Specialized Freight Trucking Local General Freight Trucking, Long-Distance General Freight Trucking, Automobiles And Heavy Equipment, Bu...

View Report

Crushed Stone Mining Global Market Report 2020 - By Type (Limestone Mining, Granite Mining)...

View Report

Telehealth Market 2021 - By Type (Software, Services, Hardware), By Mode Of Delivery (Cloud-Based, On-Premise), By Application (Teleradiology, Telepsychiatry, Telepathology, Teledermatology, Telecardiology), By End-User ...

View Report

Payer Services Global Market Report 2025 –By Outsourcing Services (Business Process Outsourcing Services, Knowledge Process Outsourcing Services, Information Technology Outsourcing Services), By Application (Revenue Cycl...

View Report

Frequently Asked Questions

What is the definition of the Cell & Gene Therapy Manufacturing Services market?

How will the Cell & Gene Therapy Manufacturing Services market drivers and restraints affect the market dynamics? What forces will shape the Cell & Gene Therapy Manufacturing Services industry going forward?

The market major growth driver - Rising Prevalence Of Cancer And Other Target Diseases To Drive Market Growth. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Cell & Gene Therapy Manufacturing Services market?

The cell & gene therapy manufacturing services market size has grown rapidly in recent years. It will grow from $8.15 billion in 2024 to $9.44 billion in 2025 at a compound annual growth rate (CAGR) of 15.9%. The growth in the historic period can be attributed to increased R&D investments, regulatory support and frameworks, growing pipeline of cell & gene therapies, industry collaborations and partnerships, increasing global demand for personalized medicine. The cell & gene therapy manufacturing services market size is expected to see rapid growth in the next few years. It will grow to " $17.92 billion in 2029 at a compound annual growth rate (CAGR) of 17.4%. The growth in the forecast period can be attributed to market maturation and commercialization, global expansion of biopharmaceutical manufacturing, increased outsourcing by pharma companies, advancements in automation and robotics, emergence of new therapeutic modalities. Major trends in the forecast period include rising demand for energy efficiency, advanced materials and technologies, compact and modular designs, electrification of transportation, focus on safety and reliability. For further insights on this market, request a sample here

How is the Cell & Gene Therapy Manufacturing Services market segmented?

The cell & gene therapy manufacturing servicesmarket covered in this report is segmented –
1) By Type: Gene Therapy; Cell Therapy
2) By Indication: Central Nervous System Disorders; Ophthalmology Diseases; Cardiovascular Diseases; Infectious Diseases; Orthopedic Diseases; Oncology Diseases
3) By Application: Commercial Manufacturing; Clinical Manufacturing
4) By End-user: Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Other End-Users Subsegments:
1) By Gene Therapy: Viral Vector Manufacturing; Plasmid DNA Production; Gene Editing Services; Formulation And Fill-Finish Services
2) By Cell Therapy: Cell Sourcing And Banking; Cell Processing And Expansion; Quality Control And Testing Services; Cryopreservation And Storage Services For further insights on this market, request a sample here

Which region has the largest share of the Cell & Gene Therapy Manufacturing Services market? What are the other regions covered in the report?

North America was the largest region in the cell and gene therapy manufacturing services market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global cell & gene therapy manufacturing services market report forecast period. The regions covered in the cell & gene therapy manufacturing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on this market, request a sample here.

Who are the major players in the Cell & Gene Therapy Manufacturing Services market?

What are the key trends in the Cell & Gene Therapy Manufacturing Services market?

Major trends in this market include Technological Advancements Driving Innovation In Cell And Gene Therapy Manufacturing Services Market. For further insights on this market, request a sample here.

Book your 30 minutes free consultation with our research experts

Cell & Gene Therapy Manufacturing Services Global Market Report 2025

Cell & Gene Therapy Manufacturing Services Market Overview

What Is Covered Under Cell & Gene Therapy Manufacturing Services Market?

What Is The Cell & Gene Therapy Manufacturing Services Market Size 2025 And Growth Rate?

What Is The Cell & Gene Therapy Manufacturing Services Market Growth Forecast?

What’s The Trade War Impact On Healthcare Services Industry?

How Is The Cell & Gene Therapy Manufacturing Services Market Segmented?

What Is Driving The Cell & Gene Therapy Manufacturing Services Market? Rising Prevalence Of Cancer And Other Target Diseases To Drive Market Growth

What Is Driving The Cell & Gene Therapy Manufacturing Services Market? Rising Adoption Of Personalized Medicines To Drive Market Growth

Who Are The Major Players In The Global Cell & Gene Therapy Manufacturing Services Market?

What Are The Key Trends Of The Global Cell & Gene Therapy Manufacturing Services Market? Technological Advancements Driving Innovation In Cell And Gene Therapy Manufacturing Services Market

What Are The Key Trends Of The Global Cell & Gene Therapy Manufacturing Services Market? Strategic Collaborations Drive Advancements In Cell And Gene Therapy Manufacturing Services Market

Cell & Gene Therapy Manufacturing Services Market Merger And Acquisition: Genezen To Acquire Uniqure's Commercial Gene Therapy

Regional Analysis For The Global Cell & Gene Therapy Manufacturing Services Market

What Defines the Cell & Gene Therapy Manufacturing Services Market?

How is Market Value Defined and Measured?

What is the Market Assessment and Strategic Outlook for the Cell & Gene Therapy Manufacturing Services Industry?

Cell & Gene Therapy Manufacturing Services Market Report Forecast Analysis

Table Of Contents

List Of Tables

List Of Figures

Frequently Asked Questions